Effect Technologies, Inc., maker of the patented EffectCheck® software for emotional analysis of communications, has introduced another upgrade to EffectCheck. The upgrade provides subscribers with the ability to assess press releases from medical and pharmaceutical companies.
“We’re pleased to be able to include this specific category of press releases within EffectCheck,” said Dr. David Fogel, Director and Co-Founder of Effect Technologies, Inc. “We know that press releases from these companies often have to include descriptions of drugs, side effects, or diseases that tend to increase evoked anxiety and depression as compared with press releases from companies in other businesses. This new category now allows a more ‘apples-to-apples’ comparison for press releases in this area.”
EffectCheck is the only patented software that provides lexical analysis of words and phrases from a 50,000-word emotional thesaurus within an easy-to-use online editor and provides subscribers with the opportunity to explore word substitutions, word impressions, and understand the flow of lexical emotion in their communications. For more information on subscribing to EffectCheck, email us email@example.com